A tüdo{combining double acute accent}rák szu{combining double acute accent}rése

Translated title of the contribution: Screening for lung cancer

Péter Barta, G. Losonczy

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The authors give an overview about the novel results and shifting paradigm of lung cancer screening. They also summarize the results of previous and most recent clinical trials, which re-directed the international interest on lung cancer screening.

Original languageHungarian
Pages (from-to)904-907
Number of pages4
JournalOrvosi Hetilap
Volume153
Issue number23
DOIs
Publication statusPublished - Jun 1 2012

Fingerprint

Early Detection of Cancer
Lung Neoplasms
Clinical Trials

ASJC Scopus subject areas

  • Medicine(all)

Cite this

A tüdo{combining double acute accent}rák szu{combining double acute accent}rése. / Barta, Péter; Losonczy, G.

In: Orvosi Hetilap, Vol. 153, No. 23, 01.06.2012, p. 904-907.

Research output: Contribution to journalArticle

@article{eacfb50428384b9a880c19065cfad245,
title = "A t{\"u}do{combining double acute accent}r{\'a}k szu{combining double acute accent}r{\'e}se",
abstract = "The authors give an overview about the novel results and shifting paradigm of lung cancer screening. They also summarize the results of previous and most recent clinical trials, which re-directed the international interest on lung cancer screening.",
keywords = "biomarker, cost effectiveness, CT, lung cancer, mortality, screening, survival",
author = "P{\'e}ter Barta and G. Losonczy",
year = "2012",
month = "6",
day = "1",
doi = "10.1556/OH.2012.29396",
language = "Hungarian",
volume = "153",
pages = "904--907",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "23",

}

TY - JOUR

T1 - A tüdo{combining double acute accent}rák szu{combining double acute accent}rése

AU - Barta, Péter

AU - Losonczy, G.

PY - 2012/6/1

Y1 - 2012/6/1

N2 - The authors give an overview about the novel results and shifting paradigm of lung cancer screening. They also summarize the results of previous and most recent clinical trials, which re-directed the international interest on lung cancer screening.

AB - The authors give an overview about the novel results and shifting paradigm of lung cancer screening. They also summarize the results of previous and most recent clinical trials, which re-directed the international interest on lung cancer screening.

KW - biomarker

KW - cost effectiveness

KW - CT

KW - lung cancer

KW - mortality

KW - screening

KW - survival

UR - http://www.scopus.com/inward/record.url?scp=84862017675&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862017675&partnerID=8YFLogxK

U2 - 10.1556/OH.2012.29396

DO - 10.1556/OH.2012.29396

M3 - Article

VL - 153

SP - 904

EP - 907

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 23

ER -